Ibuprofen has demonstrated to be a really effective painkiller, however now we have what could be a much more efficient way of administering it. Researchers in the United Kingdom in partnership with drug-delivery company Medherant came up with a clear gel patch that administers the drug over the course of half a day. It is known as the world’s first painkilling patch that releases Ibuprofen for 12 straight hours. What’s more to love for its simplicity, convenience, and can be worn discreetly under clothes.
The patch is strong enough to stick to your skin, while keeping the flexiblity it requires to prevent interfering using your body’s organic actions. For individuals who require pain alleviation rapidly, putting on one or two of those areas within the span of each day will be more simple than recalling to have a dose of painkillers for every 4 hours.
The patch may be used to administer the medication wherever it is required in a constant measure rate, and up to 30 percent of the material’s weight can be the Ibuprofen itself (most existing patches top out at 10 percent). As the team at the University of Warwick explains:
This opens the way for the development of a range of novel long-acting over-the-counter pain relief products which can be used to treat common painful conditions like chronic back pain, neuralgia and arthritis without the need to take potentially damaging doses of the drug orally. Although there are a number of popular Ibuprofen gels available these make it difficult to control dosage and are inconvenient to apply.”
Based on the reseacrhers, getting a plastic that stays towards the skin without leaving a residue was no simple job – and after beating that preliminary challenge, they had to recognize a medication that would dissolved as required.
Ibuprofen was the painkiller that fitted the bill, and Nigel Davis, CEO of Medherant, says the first consumer patches could be available and on sale within two years.
Many commercial patches surprisingly don’t contain any pain relief agents at all, they simply soothe the body by a warming effect,” says David Haddleton, one of the research chemists.
Our technology now means that we can for the first time produce patches that contain effective doses of active ingredients such as Ibuprofen for which no patches currently exist. Also, we can improve the drug loading and stickiness of patches containing other active ingredients to improve patient comfort and outcome,” he adds.